Celcuity (CELC) Accounts Payables (2016 - 2026)
Celcuity's (CELC) quarterly Accounts Payables came in at $11.4 million in Q3 2025, up 24.67% YoY from $9.2 million in Q3 2024, and up 2.33% on a QoQ basis from $11.2 million in Q2 2025.
Celcuity (CELC) Accounts Payables (2016 - 2026) Analysis & Trends
Celcuity (CELC) has 10 years of Accounts Payables data on file, last reported at $11.4 million in Q3 2025.
- Quarterly Accounts Payables rose 24.67% year-over-year to $11.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $11.4 million (up 24.67% YoY) and the FY2024 annual result came in at $820000.0, down 83.85% from the prior year.
- Accounts Payables rose to $11.4 million in Q3 2025, from $11.2 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $11.4 million in Q3 2025 to a low of $318213.0 in Q1 2021.
- A 5-year average of $4.5 million and a median of $3.0 million in 2023 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2021 — Accounts Payables surged 2000.84% — and 2024, when it sank 83.85%.
- Tracing CELC's Accounts Payables over 5 years: stood at $1.5 million in 2021, then soared by 74.31% to $2.6 million in 2022, then jumped by 93.25% to $5.1 million in 2023, then slumped by 83.85% to $820000.0 in 2024, then jumped by 1292.44% to $11.4 million in 2025.
- The last three Accounts Payables figures came in at $11.4 million (Q3 2025), $11.2 million (Q2 2025), and $9.9 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - | 8.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.09 Mn |
| Dec 31, 2025 | 6.41 Mn |
| Sep 30, 2025 | 11.42 Mn |
| Jun 30, 2025 | 11.16 Mn |
| Mar 31, 2025 | 9.93 Mn |
| Dec 31, 2024 | 820,000.00 |
| Sep 30, 2024 | 9.16 Mn |
| Jun 30, 2024 | 6.20 Mn |
| Mar 31, 2024 | 5.28 Mn |
| Dec 31, 2023 | 5.08 Mn |
| Sep 30, 2023 | 5.63 Mn |
| Jun 30, 2023 | 3.02 Mn |
| Mar 31, 2023 | 2.57 Mn |
| Dec 31, 2022 | 2.63 Mn |
| Sep 30, 2022 | 3.17 Mn |
| Jun 30, 2022 | 2.30 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 1.51 Mn |
| Sep 30, 2021 | 1.75 Mn |
| Jun 30, 2021 | 647,172.00 |